Speech-Language Pathologists in Ocean, NJ Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Esther Ehrenreich, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Deal Rd, Ocean, NJ 07712 Phone: 732-493-3670

Kevin Michael Scheier Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Kneeley Blvd, Ocean, NJ 07712 Phone: 732-493-5900

Adrienne C Ferrie, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 802 W Park Ave, Suite 211, Ocean, NJ 07712 Phone: 732-918-4848

Avigayil Levy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Deal Rd, Ocean, NJ 07712 Phone: 732-289-8492

Diane Ludwig, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 Cotswold Cir, Ocean, NJ 07712 Phone: 732-493-1858

Gabriella Didomenico Vidal, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 802 W Park Ave, Suite 211, Ocean, NJ 07712 Phone: 732-918-4848

Mrs. Leah Yurowitz, SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Poplar Pl, Ocean, NJ 07712 Phone: 732-493-3670

News Archive

Sysmex unveils latest series of haematology analysers at IFCC congress

The Sysmex Corporation, the global leader in haematology, unveiled its latest series of haematology analysers at the annual IFCC congress, EuroMedLab JIB in Paris today. The XN-L series follows in the footsteps of its game-changing big brother, the XN-Series. The new, smaller XN-L Series makes top quality haematology available for all.

Telemedicine eye screening programs could help bridge gap in caring for premature babies

Retinopathy of prematurity (ROP) occurs when abnormal blood vessels grow over the retina and may lead to blindness in premature babies.

Genzyme commences patient enrollment in Genz-112638 phase 3 trials

Genzyme Corporation today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.

MedLink qualifies for 2010 PQRI programs

MedLink announced today that the MedLink EHR has been "qualified" by the Centers for Medicare and Medicaid Services (CMS) for eligible providers to submit quality data to CMS for 2010 PQRI reporting.

Pharmacologists study first drug-resistant strain of pneumonia to enter Texas

A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.

Read more Medical News

› Verified 3 days ago